- $69.72bn
- $79.54bn
- $20.07bn
Boston Scientific cuts annual forecast, shares rise on reset (updated)
U.S. STOCKS ON THE MOVE-Certara, Otis, Twilio
Boston Scientific rises, analysts see forecast cut as reset for investors
Boston Scientific cuts 2026 profit forecast, trims revenue growth view
Boston Scientific Q1 sales, profit slightly beat estimates; FY EPS view below estimates
What to Watch in the Day Ahead - Wednesday, April 22
RBC finds Abbott Q1 readthrough positive for Dexcom, Edwards
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
Brief: Australia's Therapeutic Goods Administration Says Boston Scientific Conducting Product Correction For Accolade And Visionist Pacemakers
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM
U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
Brief: Boston Scientific Announces Conference Call Discussing First Quarter 2026 Results
Brief: Boston Scientific Receives FDA Clearance For The Asurys™ Fluid Management System
U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike
U.S. STOCKS ON THE MOVE-Energy shares, miners, Sysco
Boston Scientific rises as FDA clears new urology fluid management system
U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan
U.S. STOCKS ON THE MOVE -Flowco Holdings, Unusual Machines, Insperity
U.S. STOCKS ON THE MOVE-SolarEdge, Mosaic, Dell